{{Drugbox
| Verifiedfields = 
| Watchedfields = 
| verifiedrevid = 
| IUPAC_name = (2''S'')-3-(4-Hydroxyphenyl)-4-methyl-2-[4-(2-piperidin-1-ylethoxy)phenyl]-2''H''-chromen-7-ol
| image = Acolbifene.svg
| width = 250

<!--Clinical data-->
| tradename = 
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration = 

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion =

<!-- Identifiers -->
| CAS_number_Ref = 
| CAS_number = 252555-01-4
| CAS_supplemental = 
| class = 
| ATC_prefix = 
| ATC_suffix = 
| ATC_supplemental = 
| PubChem = 155435
| IUPHAR_ligand = 
| DrugBank_Ref = 
| DrugBank = 
| ChemSpiderID_Ref = 
| ChemSpiderID = 136930
| UNII = 
| KEGG = 
| ChEBI = 
| ChEMBL = 68055

<!--Chemical data-->
| C=29 | H=31 | N=1 | O=4
| molecular_weight = 
| SMILES = CC1=C([C@@H](OC2=C1C=CC(=C2)O)C3=CC=C(C=C3)OCCN4CCCCC4)C5=CC=C(C=C5)O
| StdInChI_Ref = 
| StdInChI = 1S/C29H31NO4/c1-20-26-14-11-24(32)19-27(26)34-29(28(20)21-5-9-23(31)10-6-21)22-7-12-25(13-8-22)33-18-17-30-15-3-2-4-16-30/h5-14,19,29,31-32H,2-4,15-18H2,1H3/t29-/m0/s1
| StdInChIKey_Ref = 
| StdInChIKey = DUYNJNWVGIWJRI-LJAQVGFWSA-N
| synonyms = EM-652; SCH-57068
}}

'''Acolbifene''' ([[International Nonproprietary Name|INN]]) (developmental code names '''EM-652, SCH-57068''') is a [[nonsteroidal]] [[selective estrogen receptor modulator]] (SERM) which, as of 2015, is in [[Phases of clinical research#Phase III|phase III]] [[clinical trial]]s for the treatment of [[breast cancer]].<ref>{{cite journal|pmid=15968821|year=2005|last1=Gauthier|first1=S|last2=Cloutier|first2=J|last3=Dory|first3=YL|last4=Favre|first4=A|last5=Mailhot|first5=J|last6=Ouellet|first6=C|last7=Schwerdtfeger|first7=A|last8=Mérand|first8=Y|last9=Martel|first9=C|last10=Simard|first10=J|last11=Labrie|first11=F|title=Synthesis and structure-activity relationships of analogs of EM-652 (acolbifene), a pure selective estrogen receptor modulator. Study of nitrogen substitution|volume=20|issue=2|pages=165–77|doi=10.1080/14756360500043448|journal=Journal of enzyme inhibition and medicinal chemistry}}</ref><ref name="AdisInsight">http://adisinsight.springer.com/drugs/800013630</ref>

==See also==
* [[List of investigational hormonal agents#Estrogenics|List of investigational hormonal agents § Estrogenics]]

==References==
{{Reflist|2}}

==External links==
* [http://adisinsight.springer.com/drugs/800013630 Acolbifene - AdisInsight]


{{Estrogens and antiestrogens}}
{{Estrogen receptor modulators}}

[[Category:Chromenes]]
[[Category:Hormonal antineoplastic drugs]]
[[Category:Phenols]]
[[Category:Piperidines]]
[[Category:Selective estrogen receptor modulators]]


{{antineoplastic-drug-stub}}